Trial Profile
Optimal Duration of Dual Antiplatelet Therapy After Drug Eluting Stent (DES) Implantation.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2018
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary)
- Indications Stent thrombosis
- Focus Adverse reactions
- Acronyms OPTIDUAL
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology
- 12 Sep 2015 Results published in the European Heart Journal.
- 03 Jun 2010 Actual initiation date added to 1 Jan 2009 as reported by ClinicalTrials.gov.